Integrin inhibitor, BTT-3033, Purity ≥98%

Cat. No.: X24-08-YM299

Integrin inhibitor, BTT-3033, Purity ≥98%

Synonym: 1259028-99-3; BTT3033; BTT 3033; 1-[4-[[1-(4-Fluorophenyl)pyrazol-4-yl]sulfonyl-methylamino]phenyl]-3-phenylurea

  • MDL: MFCD28166480
  • CAS Number: 1259028-99-3
  • Compound CID: 49841251
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BTT-3033 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.
Molecular Weight
465.12
Molecular Formula
C23H20FN5O3S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
BTT-3033 is a cytoskeletal signaling inhibitor that plays a key role in targeting integrin αvβ3, which is involved in tumor angiogenesis and metastasis.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.